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INTRODUCTION 
Corpus callosotomy (CC) has been employed in 
the management of intractable epilepsy since 
1940’ and should be considered for patients with 
generalized falling seizures with physical injury, 
recurrent life-threatening generalized convulsive 
status epilepticus or atypical absence status’. CC 
is especially useful in improving seizure control in 
patients with tonic and atonic seizures3 and those 
with a frontal lobe focus’. Tonic seizures are often 
resistant to standard medical therapy, but there 
have been a number of reports of the efficacy of 
lamotrigine (LTG) in this seizure type5-‘. The 
present report is of five patients who received 
lamotrigine following a partial or total CC. 
CASE REPORTS 
early 1990 when he was taking sodium valproate 
(VPA), carbamazepine (CBZ) and clobazam 
(CLB). Seizure frequency was reduced by some 
50% for 6 months and the seizures were tonic and 
CPS in nature. Towards the end of the year, JS 
was having some 50 seizures/month and vigabat- 
rin (VGB) replaced CLB to good effect such that 
he found full-time voluntary work supervising 
disabled people on a farm. In late 1991, there was 
a marked deterioration in seizure control with 
numerous injuries, leading to a posterior CC 
which was uneventful other than left-right 
into-ordination lasting 4 months. Two months 
post-operatively, JS was having 20 
seizures/month but no drop attacks and no 
injuries. Lamotrigine was commenced in May 
1992 with good effect, such that he now has two to 
three auras/month while taking VPA 3000 and 
LTG 500 mg/day. Vigabatrin was withdrawn. He 
has been living independently for the past 4 years 
and continues to work full time. 
Case 1 
Case 2 
Patient JS is a 29-year-old man with epilepsy for 
23 years. Initially, he was felt to have intractable 
complex partial seizures (CPS). Video-EEG 
telemetry (VEEG) in late 1989 showed the 
seizures to be tonic, lasting 3-5 s with profound 
post-ictal confusion lasting 5 minutes. At this time 
JS, whilst an intelligent person, was unemployed, 
had several seizures daily, suffered numerous 
scalp lacerations and sporadically wore a helmet. 
CC was proposed as a quality of life procedure. 
An anterior CC was performed uneventfully in 
Patient GM is a 20-year old man who had an 
acute encephalopathic illness at 16 months of age, 
and was left severely intellectually handicapped 
and very hyperactive with frequent seizures (tonic 
and tonic-clonic). There had been numerous 
injuries necessitating the use of a helmet. His 
clinical course and treatment is shown in Fig. 1. 
This includes two callosotomies (ACC and PCC), 
two episodes of clobazam tolerance at 20 and 
40 mg/day and the effect of lamotrigine. He now 
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has less than two seizures/month, is less 
hyperactive, much better behaved and is without 
a helmet. 
Case 3 
Patient RG is a 26-year-old, very obese woman 
with Down syndrome with epilepsy of 20 years 
duration. In 1987, she was having frequent drop 
attacks with facial injuries made worse by her 
weight. At that time, medication was VPA, there 
were several seizures daily and she began to wear 
a helmet. VEEG in 1989 documented tonic and 
tonic-clonic (GTCS) seizures, up to 20 a day. 
ACC was performed in late 1989 with a decrease 
in seizure frequency, but especially an improve- 
ment in behaviour and mood. Over the next year 
there were, on average, two tonic and three 
GTCS/week. This deteriorated in mid-1991 lead- 
ing to a PCC whilst taking VGB and VPA. There 
were no seizures for a month and they then 
returned at a frequency of one day. This 
worsened in late 1992 and lamotrigine was 
introduced. She has now been seizure free since 
May 1994 and is taking VPA 2000 and LTG 250 
mg/day with VGB being withdrawn. She has left 
the family home, lives in a group home, has 
abandoned her helmet, travels independently and 
attends a sheltered workshop. Attempts at weight 
loss have failed. 
Case 4 
Patient JC is a lo-year-old boy with epilepsy for 
10 years. VEEG demonstrated the seizures to be 
CPS of right frontal origin with a strong tonic 
component. In mid-1991, he was taking PHT and 
CLB. Vigabatrin was added producing a marked 
deterioration of his existing rude and destructive 
behaviour; it was ceased after 3 weeks. Due to his 
seizure frequency (about six per day) and a 
progressive social deterioration, an ACC was 
performed in late 1991 with no post-operative 
problems. Medication at this time was phenytoin 
(PHT). Seizure frequency decreased by 50% and 
a PCC was carried out uneventfully in May 1992 
which had a good effect for 2 months. The 
seizures then returned at a rate of about 10 per 
day, but behaviour was somewhat improved. 
Lamotrigine was commenced in late 1992 and 
since mid-1993, other than in association with 
intercurrent infective illnesses, he has been 
seizure free taking PHT 200 and LTG 
300mg/day. His behaviour is greatly improved 
with politeness replacing rudeness. 
Case 5 
Patient RF is a 26-year-old woman with epilepsy 
of 12 years duration. Seizure control was difficult 
from the outset with VEEG in 1989 revealing 
tonic seizures of frontal origin. At this time, there 
were two to three drop attacks daily whilst awake 
and four to six each night while taking PHT and 
CBZ. ACC was performed uneventfully in late 
1989 with a reduction in seizures whilst awake. 
Clobazam was added and VGB tried with no 
effect. In late 1992, because of six seizures whilst 
awake in 3 months, LTG was tried to a dose of 
7.7 mg/kg/day also with no effect. RF declined 
further surgery, and LTG was replaced with 
felbamate (FBM). This has improved her quality 
of life with only one seizure whilst awake (at her 
wedding) in 18 months allowing her to work full 
time. The sleep associated seizures persist. 
Medications are CBZ 800, CLB 20, PHT 250 and 
FBM 1200 mg/day; RF is not keen to change this 
unwieldy regimen. 
DISCUSSION 
This brief report suggests that the use of 
lamogrigine post corpus callosotomy has been 
beneficial in four of the five patients with 
felbamate being useful in the final patient. All 
patients have shown an improvement in quality of 
life, probably both due to the callosotomy and 
LTG or FBM. Quality of life improvement has 
been documented with LTG therapy7-9 and may 
be very dramatic”. The other striking feature was 
the improvement in behaviour in the three 
patients (cases 2,3 and 4) where this was initially 
Lamotrlgine after corpus callosotomy 
a problem. This has been documented post- 
callosotomy” and in the present patients has 
improved the quality of life of the families. 
It is thus proposed that the use of lamotrigine 
in association with corpus callosotomy be con- 
sidered in patients with tonic or frontal CPS. 
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